Rashider Aloni joined the EORTC Statistics Department as a Research Fellow in February 2026. She holds a master’s degree in Statistics and Data Science (Biostatistics) from Hasselt University, Belgium, and a bachelor’s degree in mathematics from the University of Zimbabwe. Before joining EORTC, she worked as a Research Consultant at the South African Medical Research Council,  where she contributed to infectious disease and public health research using advanced statistical modelling approaches. Her research interests include clinical trials methodology, longitudinal and survival data analysis, Bayesian methods, and infectious disease modelling. At EORTC, she will assist in statistical support and methodological contributions across various research projects.

Seren Ucak is a clinical researcher with a PhD in physiology from the University of Sydney, Australia. She has a clinical and academic background in physiology, cardiac autonomic function, and patient-centred outcomes. She has led multiple clinical studies, published first-author research on obstructive sleep apnoea phenotypes and autonomic regulation, and contributed to teaching and clinical consultancy in health. She joins the EORTC as a Quality of Life Research Fellow and will work on the project “Developing a strategy to ensure EORTC QLG measures fit changing standards for cancer clinical trials”. Her work will support the development of a framework and evidence base to ensure EORTC quality of life measures remain robust, relevant, and aligned with evolving regulatory expectations.

Andrew Kamya is a Ugandan statistician who joined the EORTC Statistics Department as a Biostatistics Fellow in October 2025. He holds two MSc degrees from Hasselt University (Belgium): Statistics with a specialization in Biostatistics, and Statistics with a specialization in Statistical Bioinformatics, as well as a BSc in Mathematics and Chemistry from Makerere University (Uganda). He previously trained at the MRC/UVRI Uganda Virus Research Institute, where he contributed to literature reviews, data curation, and research workshops in medical research. His master’s thesis, conducted in collaboration with the EORTC, developed Bayesian mixed-effects models for longitudinal toxicity using patient-level data from EORTC trials 62091 and 30974. His interests include survival and longitudinal modeling, Bayesian data analysis, and clinical trials. At the EORTC, he works on multiple projects, including an individual participant data meta-analysis on perioperative HER2-targeted therapy in gastric and EGJ cancer, research projects in brain tumors, and the IOPTIMISE program on clinical and biological determinants of immunotherapy efficacy and safety in solid tumors.

Myrto Moutafi joined the EORTC as a Research Fellow with the Medical Department in September 2025. She is a Greek Medical Doctor with a specialist training in Medical Oncology at Attikon University Hospital, Athens, Greece and has a special interest in lung and head and neck cancer. She holds a PhD in Cancer Biomarkers in Immune and Targeted Therapies from the National and Kapodistrian University Athens, part of which she conducted at Yale School of Medicine. She has contributed to the design of a clinical trial in Head and Neck Cancer as part of her oncology fellowship. Her research interests include immunotherapy resistance, biomarker discovery, and the integration of artificial intelligence into clinical oncology. At EORTC, she will focus on the IOPTIMISE project, investigating clinical and biological determinants of immunotherapy efficacy and safety across solid tumours.

King Teck Long joined EORTC as a Research Fellow in the Medical Department in September 2025. He is a Malaysian pharmacist with over 10 years of experience in clinical research. He holds a Bachelor of Pharmacy (Hons) from International Medical University, Kuala Lumpur. He worked at the Clinical Research Centre of Sarawak General Hospital, where he led Investigational Drug Services, including investigational product management, pharmacy care, and drug information in clinical trials. He was also involved in study design, protocol development, and coordination of investigator-initiated studies, as well as safety reviews and risk assessments for First-in-Human studies at the centre. At EORTC, he is training in cancer research methodology and contributing to projects focused on reforming trial eligibility criteria and improving patient information and consent materials through patient input.

Alvina Vadassery is an Indian medical doctor with specialization in Radiation Oncology which she obtained at Tata Memorial Centre, Mumbai. She also holds a master’s degree in health sciences with major in Clinical Epidemiology from Erasmus Medical Centre, Rotterdam. She joined the EORTC as a medical Fellow with the Medical Department. Additionally, she is pursuing PhD at University of Groningen, The Netherlands. She has a diverse professional experience as a clinical and radiation oncologist, clinical researcher, and area medical advisor at pharmaceutical MNC. Her previous research experience includes quality of life study in bladder cancer patients, prediction modelling of cosmetic outcomes in breast cancer and dysphagia assessment in head neck cancer. As part of her fellowship and PhD at the EORTC and university of Groningen, Alvina will utilize her diverse experience and will work on optimization of clinical trials in head neck cancer. Additionally, she would be actively involved in the daily operations of the EORTC Head and Neck Cancer Group (HNCG) and will collaborate across the international trial network of the EORTC.

Christopher Cronin joined the EORTC as a Research Fellow with the Medical Department and Executive Office in July 2025. He is an Irish Medical Doctor and holds a Bachelor in Medicine from the University of Galway, and an MSc in Leadership and Innovation in Healthcare from the Royal College of Surgeons in Ireland. Christopher will shortly complete specialist training in Medical Oncology with the Royal College of Physicians in Ireland and has a special interest in lung cancer, and methodological approaches to patient-centred research. As part of his fellowship, Christopher will examine approaches to endpoint selection and data collection in published pragmatic trials in oncology. His project aims to develop a framework for selecting endpoints in pragmatic trials, incorporating quality of life and health economics dimensions, and will also consider proportional and risk-based strategies for data collection.

Andreia is a Brazilian researcher and lecturer with a background in public health. She holds a PhD in Social Sciences from Aarhus University, Denmark, and a master’s degree in Public Health Nutrition from Ghent University. Earlier in her career, Andreia worked as a clinical nutritionist in São Paulo before pursuing opportunities in international academia—an experience for which she is deeply grateful. Andreia joined EORTC at the beginning of 2025 as a fellow in Quality of Life. She will work on the project “Evidence generation for side effect burden item Q168”, contributing with the qualitative approach of this mix-methods, cross-country research.

Raffaella De Pietro is an Italian medical doctor with a specialization in Radiation Oncology, which she obtained at Sapienza University of Rome. During her education, Raffaella gained experience in the neuro-oncological field and spent the last year focusing on neuro-oncological clinical trials. She joined EORTC at the beginning of 2025 as a fellow in Radiation Therapy Quality Assurance (RTQA). Her project will focus on evaluating the necessity of RTQA in glioblastoma trials, correlating RTQA with patient outcomes.

Lyse Naomi Wamba joined the EORTC as a Biostatistician Fellow in November 2024. Born and raised in Cameroon, she moved to Belgium in 2017 to pursue a Master’s in Statistics, followed by a PhD at KU Leuven. Her PhD, conducted in collaboration with the University Hospital of Leuven, focused on the application of machine learning tools for predicting patients’ length of stay. At EORTC, she will be working with the Brain Tumour Group, starting with an assessment of the prognostic significance of haematological toxicity induced by a specific polychemotherapy. In her free time, she enjoys reading a good book.

Laure Musekera Murerwa joined the EORTC in November 2024. Raised in Belgium, she holds a master’s degree in statistics from UC Louvain in Louvain-la-Neuve. Before joining the EORTC, she held a position at the Belgian Ministry of Finance, where she was responsible for analysing data from large entreprises. She also collaborated with other European tax authorities to develop guidelines for the application of AI in fiscal matters. During her tenure in the public sector, Laure obtained a certification in biostatistics. At the EORTC, she will contribute to research projects on various topics, including gastric cancer treatments and the resectability of stage III non-small-cell lung cancer.

Tetsuya Sekita joined the EORTC as a Medical Fellow in October 2024. He is an orthopaedic surgeon specializing in sarcoma treatment. He earned his PhD from Keio University in Tokyo, Japan, and has experience in both clinical sarcoma care and basic research, having previously worked at the National Cancer Center in Japan. He also spent a year and a half at the Japan Clinical Oncology Group (JCOG) headquarters, where he trained in clinical research methodology and served as a study coordinator. During his fellowship at the EORTC, he will be actively involved in the daily operations of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) trials and will work to strengthen collaborative ties between EORTC and JCOG.

Lydia Champezou joined EORTC as a Fellow Biostatistician on August 2024. She is from Greece and holds a Bachelor’s degree in Mathematics from the Aristotle University of Thessaloniki and a Master’s degree in Biostatistics from the National and Kapodistrian University of Athens. After her studies, she worked at Frontier Science Foundation Hellas (FSF-H), where she was introduced in clinical trials. Her work was focused on researching joint models for longitudinal and time-to-event data, while she also participated in projects with ESMO, such as the Women for Oncology (W4O) project and the Magnitude of Clinical Benefit Scale (MCBS) research project. Recently, she completed a traineeship at the European Centre for Diseases Control and Prevention (ECDC), where she worked on impact analysis of COVID-19 and on STI modelling to investigate the increases in EU/EEA. In addition, she was a member of the research and development team of the European Respiratory Diseases Forecasting Hub (RespiCast). At EORTC, she will work on Melanoma projects, starting with a translational analysis that focuses on auto-antibodies and the outcome of patients treated with adjuvant pembrolizumab and placebo in the 1325 trial.

Fanny Hoogstoel joined the EORTC statistics department as a fellow in August 2024. She holds a master’s degree in Statistics Modeling and Data Science in Public Health (Medicine Sorbonne University, Paris, France) and Bioinformatics Biostatistics (Paris Saclay University, France) as well as a bachelor’s degree in mathematics (University of Nantes, France). Before joining EORTC, she worked as a teaching assistant at UC Louvain (Belgium) where she had the opportunity to give statistics courses for bachelor’s and master’s students, was a consultant for the Statistical Methodology and Computing Service, and was involved in research in biostatistics, especially on survival analysis. At the EORTC, she will work on multiple projects, beginning with one on rare sarcomas.

Fábio Cardoso Borges joined the EORTC in January 2024 as a Research Fellow at the Executive Office. He is Portuguese and holds a master’s degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon (FFULisboa). He has previously worked as a researcher in (pharmaco)epidemiology and outcomes research at the Portuguese Cancer Registry (RON at IPO Lisboa) and as a Project Manager at the EORTC. Concurrently, he has been working as a health technology assessment (HTA) assessor for the Portuguese HTA agency (INFARMED I.P.). Considering his particular interest on the methodological aspects of clinical studies and in regulatory and HTA decision-making, Fábio will focus on optimising the clinical research landscape for anticancer treatments during his fellowship at the EORTC. His project aims to identify evidence gaps, assess the value of pragmatic clinical trials in bridging the efficacy-effectiveness gap, and propose how the established clinical research paradigm can be adapted to incorporate pragmatic clinical trials as a tool to bridge the evidence gaps experienced in oncology by decision-makers.

Volha Hertsyk is a Belarusian professional who holds an advanced master’s degree in medical physics earned through the collaborative program of IAEA, ICTP and University of Trieste in Italy. Her career began as a technician in the radiotherapy department at the National Cancer Centre of Belarus, where she later advanced to the role of engineer. Her responsibilities included linac’s simple troubleshooting, treatment planning and quality assurance program creation. Furthermore, she gained two years of clinical experience in two different Italian hospitals with such duties as routine linac QA, treatment planning, and reviewing quality assurance documentation. She joined EORTC in September 2023 to become a part of the RTQA family and collaborate on the constantly evolving process for radiotherapy quality improvement.